Literature DB >> 12861133

Estrogen and progesterone receptor subtype expression in normal and malignant ovarian epithelial cell cultures.

Andrew J Li1, Rae Lynn Baldwin, Beth Y Karlan.   

Abstract

OBJECTIVE: Epidemiologic data suggest that the malignant transformation of ovarian epithelium may be linked to altered steroid hormone homeostasis. STUDY
DESIGN: Estrogen receptor-alpha, estrogen receptor-beta, progesterone receptor A, and progesterone receptor B messenger RNA and protein expression were evaluated by reverse transcriptase-polymerase chain reaction and Western blot analysis in primary cell cultures of human ovarian surface epithelium (n = 23 cultures) and Cedars-Sinai ovarian cancer (n = 23 cultures).
RESULTS: The ratio of estrogen receptor-alpha/estrogen receptor-beta messenger RNA expression was 10 times higher in primary ovarian cancer cultures (9.94 +/- 3.90) than in normal ovarian surface epithelium cultures (1.00 +/- 0.16, P =.04). Estrogen receptor-alpha/estrogen receptor-beta protein ratio in primary ovarian cancer cultures (2.13 +/- 0.43) was twice that of normal human ovarian surface epithelium cultures (1.00 +/- 0.13, P =.05). Individual estrogen receptor-alpha and estrogen receptor-beta messenger RNA and protein expression were not significantly different. Progesterone receptor B protein levels in primary ovarian cancer cultures (2.08 +/- 0.42) were twice that of normal surface ovarian epithelium cultures (1.00 +/- 0.10, P =.04), although differences in progesterone receptor B messenger RNA and progesterone receptor A protein expression were not observed.
CONCLUSION: Malignant ovarian epithelial cells demonstrated multiple alterations in the expression of sex steroid hormone receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861133     DOI: 10.1067/mob.2003.328

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  16 in total

Review 1.  Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis.

Authors:  Gwendal Lazennec
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

2.  Ovarian surface epithelium receptors during pregnancy and estrus cycle of rats with emphasis on steroids and gonadotropin fluctuation.

Authors:  Salina Y Saddick
Journal:  Saudi J Biol Sci       Date:  2014-03-13       Impact factor: 4.219

3.  Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.

Authors:  Susan M Dougherty; Williard Mazhawidza; Aimee R Bohn; Krista A Robinson; Kathleen A Mattingly; Kristy A Blankenship; Mary O Huff; William G McGregor; Carolyn M Klinge
Journal:  Endocr Relat Cancer       Date:  2006-03       Impact factor: 5.678

4.  Genetic polymorphisms in the estrogen receptor beta (ESR2) gene and the risk of epithelial ovarian carcinoma.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Katharine E McDuffie; Michael E Carney; Keith Y Terada; Marc T Goodman
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

Review 5.  New insights on the role of hormonal therapy in ovarian cancer.

Authors:  Fiona Simpkins; Arlene Garcia-Soto; Joyce Slingerland
Journal:  Steroids       Date:  2013-02-08       Impact factor: 2.668

6.  Epigenetic modifications of the Estrogen receptor beta gene in epithelial ovarian cancer cells.

Authors:  Oi Wah Stephanie Yap; Ganapathy Bhat; Liang Liu; Trygve O Tollefsbol
Journal:  Anticancer Res       Date:  2009-01       Impact factor: 2.480

7.  Transcription factor-microRNA-target gene networks associated with ovarian cancer survival and recurrence.

Authors:  Kristin R Delfino; Sandra L Rodriguez-Zas
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

8.  Estrogen receptor alpha expression in ovarian cancer predicts longer overall survival.

Authors:  Agnieszka Halon; Verena Materna; Malgorzata Drag-Zalesinska; Ewa Nowak-Markwitz; Tserenchunt Gansukh; Piotr Donizy; Marek Spaczynski; Maciej Zabel; Manfred Dietel; Hermann Lage; Pawel Surowiak
Journal:  Pathol Oncol Res       Date:  2011-01-06       Impact factor: 3.201

9.  Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.

Authors:  Galina Lurie; Lynne R Wilkens; Pamela J Thompson; Yurii B Shvetsov; Rayna K Matsuno; Michael E Carney; Rachel T Palmieri; Anna H Wu; Malcolm C Pike; Celeste L Pearce; Usha Menon; Aleksandra Gentry-Maharaj; Simon A Gayther; Susan J Ramus; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Paul D P Pharoah; Honglin Song; Jacek Gronwald; Anna Jakubowska; Cezary Cybulski; Jan Lubinski; Joellen M Schildkraut; Andrew Berchuck; Susanne Krüger Kjær; Estrid Høgdall; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Alexander Hein; Georgia Chenevix-Trench; Penelope M Webb; Jonathan Beesley; Marc T Goodman
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

10.  Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.

Authors:  Sanjib Chaudhary; Aditya K Panda; Dipti Ranjan Mishra; Sandip K Mishra
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.